Company intelligence / Profile preview
Rafa Laboratories
- Ownership
- Private
- Development stage
- Other
Overview
Rafa Laboratories has a long-standing commercial presence in Israel with approved products including autoinjectors for emergency use and status epilepticus treatments. Their atropine autoinjectors are FDA-approved for both adult and pediatric use. The company supplies medical countermeasures globally to governments and military forces, with cGMP-compliant manufacturing facilities.
- Therapeutic areas
- PulmonologyOtherDermatologyGastroenterologyNeurology
- Modalities
- Small moleculesSterile and aseptic injectable liquidsCombination devices (e.g., autoinjectors)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Rafa Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rafa Laboratories.